APA (7th ed.) Citation

K, C. M., MF, D., J, P., J, T., L, M., JA, S., . . . MS, F. (2019). Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study. Clinical pharmacology and therapeutics, 105(5), 1234. https://doi.org/10.1002/cpt.1258

Chicago Style (17th ed.) Citation

K, Chris Min, et al. "Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study." Clinical Pharmacology and Therapeutics 105, no. 5 (2019): 1234. https://doi.org/10.1002/cpt.1258.

MLA (9th ed.) Citation

K, Chris Min, et al. "Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study." Clinical Pharmacology and Therapeutics, vol. 105, no. 5, 2019, p. 1234, https://doi.org/10.1002/cpt.1258.